Shree Ganesh Rem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE414Y01015
  • NSEID:
  • BSEID: 540737
INR
585.00
25.3 (4.52%)
BSENSE

Jun 18

BSE+NSE Vol: 5.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jenburkt Pharma
Kopran
Anlon Healthcare
Shree Ganesh Rem
Kilitch Drugs
Amanta Healthcar
Zim Laboratories
Anuh Pharma
Sigachi Indust.
Bharat Parenter.
Influx Health.
Why is Shree Ganesh Remedies Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.20 times
2
The company has declared Negative results for the last 4 consecutive quarters
  • INTEREST(9M) At Rs 2.69 cr has Grown at 49.44%
  • PAT(Q) At Rs 3.09 cr has Fallen at -43.0%
  • ROCE(HY) Lowest at 16.18%
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 21-May-26 and has generated 7.05% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
With ROE of 10.9, it has a Expensive valuation with a 4.9 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 6.02%, its profits have fallen by -23%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Shree Ganesh Rem should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shree Ganesh Rem for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shree Ganesh Rem
-4.24%
0.14
43.90%
Sensex
-4.95%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.37%
EBIT Growth (5y)
16.32%
EBIT to Interest (avg)
15.48
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.78
Tax Ratio
26.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
20.65%
ROE (avg)
13.40%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
42
Industry P/E
34
Price to Book Value
4.61
EV to EBIT
30.76
EV to EBITDA
21.57
EV to Capital Employed
4.50
EV to Sales
6.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.64%
ROE (Latest)
10.90%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
DEBT-EQUITY RATIO(HY)

Lowest at 0.24 times

-23What is not working for the Company
INTEREST(9M)

At Rs 2.69 cr has Grown at 49.44%

PAT(Q)

At Rs 3.09 cr has Fallen at -43.0%

ROCE(HY)

Lowest at 16.18%

NET SALES(Q)

Lowest at Rs 21.11 cr

PBDIT(Q)

Lowest at Rs 6.74 cr.

PBT LESS OI(Q)

Lowest at Rs 3.32 cr.

EPS(Q)

Lowest at Rs 2.41

Loading Valuation Snapshot...
Here's what is working for Shree Ganesh Rem
Debt-Equity Ratio - Half Yearly
Lowest at 0.24 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Shree Ganesh Rem
Net Sales - Quarterly
At Rs 21.11 cr has Fallen at -21.96%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 3.32 cr has Fallen at -51.32%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 3.09 cr has Fallen at -43.0%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Nine Monthly
At Rs 2.69 cr has Grown at 49.44%
over preceding nine months period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Net Sales - Quarterly
Lowest at Rs 21.11 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 6.74 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 3.32 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 2.41
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)